Nanci Hawley‐Foss

756 total citations
19 papers, 588 citations indexed

About

Nanci Hawley‐Foss is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Nanci Hawley‐Foss has authored 19 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 11 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Nanci Hawley‐Foss's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (9 papers) and Immune Cell Function and Interaction (6 papers). Nanci Hawley‐Foss is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (9 papers) and Immune Cell Function and Interaction (6 papers). Nanci Hawley‐Foss collaborates with scholars based in Canada, United States and Vietnam. Nanci Hawley‐Foss's co-authors include D. William Cameron, Keith Gallicano, Jonathan B. Angel, Andrew D. Badley, Sharon Cassol, Gary Garber, Paul MacPherson, Stephen Kravcik, Virginia Roth and Jan Sahai and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Virology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Nanci Hawley‐Foss

19 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nanci Hawley‐Foss Canada 10 341 298 167 160 68 19 588
Laura Zamora Spain 9 310 0.9× 410 1.4× 122 0.7× 233 1.5× 41 0.6× 19 669
Brian Gazzard United Kingdom 15 337 1.0× 480 1.6× 41 0.2× 223 1.4× 40 0.6× 37 797
Rebekah Puls Australia 16 425 1.2× 421 1.4× 88 0.5× 109 0.7× 67 1.0× 26 639
S Sabally Gambia 10 252 0.7× 211 0.7× 120 0.7× 153 1.0× 21 0.3× 10 442
Lorna Leal Spain 16 273 0.8× 365 1.2× 152 0.9× 112 0.7× 203 3.0× 42 648
Osvalda Rampon Italy 14 306 0.9× 292 1.0× 106 0.6× 151 0.9× 35 0.5× 30 573
James Stanford United States 8 711 2.1× 955 3.2× 36 0.2× 286 1.8× 50 0.7× 9 1.1k
Shannon Schrader United States 11 487 1.4× 582 2.0× 59 0.4× 91 0.6× 27 0.4× 18 700
Beatrice Kallungal United States 6 441 1.3× 390 1.3× 122 0.7× 73 0.5× 75 1.1× 7 636
Sarah W. Read United States 11 242 0.7× 233 0.8× 162 1.0× 109 0.7× 85 1.3× 19 521

Countries citing papers authored by Nanci Hawley‐Foss

Since Specialization
Citations

This map shows the geographic impact of Nanci Hawley‐Foss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanci Hawley‐Foss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanci Hawley‐Foss more than expected).

Fields of papers citing papers by Nanci Hawley‐Foss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanci Hawley‐Foss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanci Hawley‐Foss. The network helps show where Nanci Hawley‐Foss may publish in the future.

Co-authorship network of co-authors of Nanci Hawley‐Foss

This figure shows the co-authorship network connecting the top 25 collaborators of Nanci Hawley‐Foss. A scholar is included among the top collaborators of Nanci Hawley‐Foss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanci Hawley‐Foss. Nanci Hawley‐Foss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kravcik, Stephen, Keith Gallicano, Virginia Roth, et al.. (2006). Cerebrospinal Fluid HIV RNA and Drug Levels With Combination Ritonavir and Saquinavir. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 21(5). 371–371. 3 indexed citations
2.
Jiang, Janina, et al.. (2003). Production of CD8 + T Cell Nonlytic Suppressive Factors by CD28, CD38, and HLA-DR Subpopulations. AIDS Research and Human Retroviruses. 19(6). 497–502. 5 indexed citations
3.
MacPherson, Paul, et al.. (2001). Interleukin-7 Receptor Expression on CD8 + T Cells Is Reduced in HIV Infection and Partially Restored With Effective Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(5). 454–457. 96 indexed citations
4.
Hawley‐Foss, Nanci, Georgina Mbisa, Julian J. Lum, et al.. (2001). Effect of Cessation of Highly Active Antiretroviral Therapy during a Discordant Response: Implications for Scheduled Therapeutic Interruptions. Clinical Infectious Diseases. 33(3). 344–348. 7 indexed citations
5.
Lum, Julian J., André A. Pilon, Jaime Sanchez-Dardon, et al.. (2001). Induction of Cell Death in Human Immunodeficiency Virus-Infected Macrophages and Resting Memory CD4 T Cells by TRAIL/Apo2L. Journal of Virology. 75(22). 11128–11136. 83 indexed citations
6.
Maslove, David M., et al.. (2001). Modulation of HIV transcription by CD8+ cells is mediated via multiple elements of the long terminal repeat. Clinical & Experimental Immunology. 125(1). 102–109. 2 indexed citations
7.
MacPherson, Paul, et al.. (2001). Interleukin-7 Receptor Expression on CD8 + T Cells Is Reduced in HIV Infection and Partially Restored With Effective Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(5). 454–457. 6 indexed citations
8.
Angel, Jonathan B., Francis Mandy, Keith Gallicano, et al.. (2000). Decreased HIV-Associated T Cell Apoptosis by HIV Protease Inhibitors. AIDS Research and Human Retroviruses. 16(6). 559–567. 72 indexed citations
9.
Kravcik, Stephen, Keith Gallicano, Virginia Roth, et al.. (1999). Cerebrospinal Fluid HIV RNA and Drug Levels With Combination Ritonavir and Saquinavir. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 21(5). 371–371. 71 indexed citations
10.
Kravcik, Stephen, Keith Gallicano, Virginia Roth, et al.. (1999). Cerebrospinal Fluid HIV RNA and Drug Levels With Combination Ritonavir and Saquinavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 21(5). 371–371. 51 indexed citations
11.
Sutherland, Donald, et al.. (1998). Effect of Antiretroviral Therapy and Viral Load on the Perceived Risk of HIV Transmission and the Need for Safer Sexual Practices. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(2). 124–129. 62 indexed citations
12.
Pilon, Richard, et al.. (1998). Amplicor HIV Monitor, NASBA HIV-1 RNA QT and Quantiplex HIV RNA version 2.0 viral load assays: a Canadian evaluation. Journal of Clinical Virology. 11(3). 189–202. 16 indexed citations
13.
Kravcik, Stephen, et al.. (1996). Impact of Mycobacterium avium Complex Prophylaxis on the Incidence of Mycobacterial Infections and Transfusion-Requiring Anemia in an HIV-Positive Population. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 13(1). 27–32. 6 indexed citations
14.
Sahai, Jan, et al.. (1995). A Phase I Evaluation of Concomitant Rifabutin and Didanosine in Symptomatic HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 9(3). 274???279–274???279. 7 indexed citations
15.
Sahai, Jan, et al.. (1993). Cations in the didanosine tablet reduce ciprofloxacin bioavailability. Clinical Pharmacology & Therapeutics. 53(3). 292–297. 52 indexed citations
16.
Conway, Barbara R., et al.. (1993). Letrazuril therapy for cryptosporidiosis. AIDS. 7(3). 438–439. 2 indexed citations
17.
Sahai, Jan, Keith Gallicano, Gary Garber, et al.. (1992). Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus. Clinical Pharmacology & Therapeutics. 52(5). 464–470. 8 indexed citations
18.
Sahai, Jan, Keith Gallicano, Gary Garber, et al.. (1992). The effect of a protein meal on zidovudine pharmacokinetics in HIV‐ infected patients.. British Journal of Clinical Pharmacology. 33(6). 657–660. 16 indexed citations
19.
Cameron, D. William, et al.. (1991). The use of ozone-treated blood in the therapy of HIV infection and immune disease. AIDS. 5(8). 981–984. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Zamora Breakdown of academic impact, for papers by Brian Gazzard Breakdown of academic impact, for papers by Rebekah Puls Breakdown of academic impact, for papers by S Sabally Breakdown of academic impact, for papers by Lorna Leal Breakdown of academic impact, for papers by Osvalda Rampon Breakdown of academic impact, for papers by James Stanford Breakdown of academic impact, for papers by Shannon Schrader Breakdown of academic impact, for papers by Beatrice Kallungal Breakdown of academic impact, for papers by Sarah W. Read
Rankless by CCL
2026